P16INK4A overexpression is a useful marker for uterine cervix lesions;La surexpression de p16INK4A est un marqueur utile des lésions du col utérin

Annales de Biologie Clinique

Volumn 68, Issue 4, 2010, Pages 409-414

  Missaoui, Nabiha ^a,b   Hmissa, Sihem ^b   Sankaranarayanan, Rengaswamy ^c   Deodhar, Kedar ^e   Nene, Bhagwan ^d   Budukh, Atul ^d   Malvi, Sylla ^e   Chinoy, Roshini ^e   Kelkar, Roshni ^e   Kane, Shubhada ^e   Chauhan, Madanmohan ^d   Kothai, Ashok ^d   Kahate, Smita ^d   Fontanière, Bernard ^f   Frappart, Lucien ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b FARHAT HACHED HOSPITAL   (Tunisia)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d Nargis Dutt Memorial Cancer Hospital (NDMCH)   (India)

^e TATA MEMORIAL HOSPITAL   (India)

^f CENTRE LÉON BÉRARD   (France)

Author keywords

Cancer; CIN; Diagnosis; HPV; P16INK4A overexpression; Uterine cervix

Indexed keywords

HUMAN PAPILLOMAVIRUS;

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ARTICLE; CANCER STAGING; FEMALE; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; HUMAN; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; PATHOLOGY; PRECANCER; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR SUPPRESSOR GENE; UTERINE CERVIX DISEASE; UTERINE CERVIX TUMOR; VIROLOGY;

CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; GENETIC MARKERS; HUMANS; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; RISK FACTORS; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS;

EID: 77955859293     PISSN: 00033898     EISSN: 19506112     Source Type: Journal    
DOI: 10.1684/abc.2010.0458     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Wells M, Ostor AG, Crum CP, Franceschi S, Tommasino M, Nesland JM, et al. Tumours of the breast and female genital organs. IARC Press, Lyon 2003, France, Lyon.
3. Robertson AJ, Anderson JM, Beck JS, Burnett RA, Howatson SR, Lee FD, et al Observer variability in histopathological reporting of cervical biopsy specimens. J Clin Pathol 1989; 42: 231-238
4. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-350
5. Munger K, Howley PM. Human papillomavirus immortalization and transformation functions. Virus Res 2002; 89: 213-228
6. Khleif SN, DeGregori J, Yee CL, Otterson GA, Kaye FJ, Nevins JR, et al. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci USA 1996; 93: 4350-4354
7. Keating JT, Cviko A, Riethdorf S, Riethdorf L, Quade BJ, Sun D, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus related cervical neoplasia. Am JSurg Pathol 2001; 25: 884-891
8. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U. Overexpression of p16INK4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92: 276-284
9. von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 2002; 38: 2229-2242
10. Missaoui N, Hmissa S, Frappart L, Trabelsi A, Abdelkader AB, Traore C, et al. p1616INK4A overexpression and HPV infection in uterine cervix adenocarcinoma. Virchows Archiv 2006; 448: 597-603.
11. Murphy N, Ring M, Killalea AG, Uhlmann V, O'Donovan M, Mulcahy F, et al. p1616INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 2003; 56: 56-63.
12. Milde-Langosch K, Riethdorf S, Kraus-Poppinghaus A, Riethdorf L, Loning T. Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas. Vrchows Arch 2001; 439: 55-61.
13. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998; 153: 1741-1748
14. Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopoulos G, Martin-Hirsch P, et al. p16INK4a immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev 2009; 35: 210-220
15. Sankaranarayanan R, Nene B, Dinshaw KA, Mahe C, Jayant K, Shastri SS, et al. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer 2005; 116: 617-623
16. McCluggage WG, Jenkins D. p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma. Int JGynecol Pathol 2003; 22: 231-235
17. Wang SS, Trunk M, Schiffman M, Herrero R, Sherman ME, Burk RD, et al. Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. Cancer Epidemiol Biomarkers Prev 2004; 13: 1355-1360
18. Agoff SN, Lin P, Morihara J, Mao C, Kiviat NB, Koutsky LA. p16 (INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 2003; 16: 665-673
19. Gupta R, Srinivasan R, Nijhawan R, Suri V, Uppal R. Protein p 1616INK4A expression in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of uterine cervix. Indian J Pathol Microbiol 2010; 53: 7-11.
20. Benevolo M, Mottolese M, Marandino F, Vocaturo G, Sindico R, Piperno G, et al. Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions. Mod Pathol 2006; 19: 384-391
21. . Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002; 26: 1389-1399
22. Kalof AN, Cooper K. p16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia. Adv Anat Pathol 2006; 13: 190-194
23. Murphy N, Heffron CC, King B, Ganuguapati UG, Ring M, McGuinness E, et al. p1616INK4A positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem. Virchows Arch 2004; 445: 610-615
24. Carozzi F, Cecchini S, Confortini M, Becattini V, Cariaggi MP, Pontenani G, et al. Role of p16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology. Cancer 2006; 108: 119-123
25. Kurshumliu F, Thorns C, Gashi-Luci L. p1616INK4A in routine practice as a marker of cervical epithelial neoplasia. Gynecol Oncol 2009; 115: 127-131
26. Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopoulos G, Martin-Hirsch P, et al. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev 2009; 35: 210-220
27. Walts AE, Bose S. p16, Ki-67, and BD ProEx™C immunostaining: a practical approach for diagnosis of cervical intraepithelial neoplasia. Hum Pathol 2009; 40: 957-964
28. Branca M, Ciotti M, Santini D, Di Bonito L, Giorgi C, Benedetto A, et al. p16(INK4A) expression is related to grade of CIN and high-risk human papillomavirus but does not predict virus clearance after coniza- tion or disease outcome. Int J Gynecol Pathol 2004; 23: 354-365
29. Volgareva G, Zavalishina L, Andreeva Y, Frank G, Krutikova E, Golovina D, et al. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells. BMC Cancer 2004; 4: 58.
30. Sano T, Masuda N, Oyama T, Nakajima T. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int 2002; 52: 375-383
31. . von Knebel Doeberitz M. New molecular tools for efficient screening of cervical cancer. Dis Markers 2001; 17: 123-128
32. Lambert AP, Anschau F, Schmitt VM. p1616INK4A expression in cervical premalignant and malignant lesions. Exp Mol Pathol 2006; 80: 192-196
33. Choo KB, Lee HH, Pan CC, Wu SM, Liew LN, Cheung WF, et al. Sequence duplication and internal deletion in the integrated human papillomavirus type 16 genome cloned from a cervical carcinoma. J Virol 1988; 62: 1659-1666